SUN Pharmaceutical Industries Limited Gliclazide Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Gliclazide Export Records India — #3 Exporter, 470 Shipments, $15.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

SUN Pharmaceutical Industries Limited — Gliclazide Exporter #3 | $15.1M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Gliclazide Exporter Profile

Indian Pharmaceutical Exporter · #3 for Gliclazide · $15.1M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #3 Indian exporter of Gliclazide with $15.1M in export value and 470 verified shipments. SUN Pharmaceutical Industries Limited holds a 5.0% market share in Gliclazide exports across 11 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Gliclazide Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Gliclazide export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Gliclazide?

Country	Value	Shipments	Share
BRAZIL	$8.8M	298	80.1%
CANADA	$1.4M	62	12.8%
BELGIUM	$439.9K	89	4.0%
MYANMAR	$118.8K	13	1.1%
UNITED ARAB EMIRATES

Who Are the Top Buyers of Gliclazide from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
RANBAXY FARMACEUTICA LTDA :	BRAZIL	$2.0M	76
M/S. RANBAXY FARMACEUTICA LTDA :	BRAZIL	$1.9M	48
SUN PHARMA CANADA INC.	CANADA	$616.1K	27
M/S. SUN FARMACEUTICA DO BRAZIL LTD	BRAZIL	$592.7K	14
SUN PHARMA CANADA INC	CANADA	$573.5K	26
RANBAXY FARMACEUTICA LTDA	BRAZIL	$475.3K	26
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$439.9K	89
M/S. RANBAXY FARMACEUTICA LTDA,	BRAZIL	$431.0K	12
M S RANBAXY FARMACEUTICA LTDA	BRAZIL	$419.0K	9
RANBAXY FARMACEUTICA LIMITED	BRAZIL	$402.8K	9

SUN Pharmaceutical Industries Limited supplies Gliclazide to 47 buyers globally. The largest buyer is RANBAXY FARMACEUTICA LTDA : (BRAZIL), followed by M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL) and SUN PHARMA CANADA INC. (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Gliclazide Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
GLICLAZIDE RXY TAB 30mg 50X10B EACH CONTAINS: GLICLAZIDE MODIFIED RELEASE TABLETS 30 mg : PACK : Box50x10s	$431.4K	11
GLICLAZIDE TAB 60 MG 50X10b PACK:BOX50X1	$392.5K	8
GLICLAZIDE SUN TAB 30MG 10X50b(OF)BR PAC	$368.7K	8
GLICLAZIDE RXY TAB 30MG 4X15b PACK:4X15(	$241.2K	5
GLICLAZIDE TAB 60MG 50X10b PACK:BOX50X10	$203.8K	7
GLICLAZIDE SUN TAB 30MG 20X50b(OF)BR PA	$200.0K	4
GLICLAZIDE TAB 60mg contains GliclazidePACK : Box60s	$200.0K	4
GLICLAZIDE RXY TAB 30mg 50X10B EACH CONTAINS: GLICLAZIDE MODIFIED RELEASE TABLETS 30 mg PACK : Box50x10s	$195.0K	5
GLICLAZIDE MODIFIED RELEASE TABLETS 30MG	$184.1K	6
GLICLAZIDE TAB 60MG 3X10b BRAZ PACK:BOX3	$176.4K	4

SUN Pharmaceutical Industries Limited exports 232 distinct Gliclazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GLICLAZIDE RXY TAB 30mg 50X10B EACH CONTAINS: GLICLAZIDE MOD with 11 shipments worth $431.4K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Gliclazide Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$15.1M	470	11	$32.2K
4	MICRO LABS LIMITED	$7.6M	205	17	$37.2K
5	IPCA LABORATORIES LIMITED	$7.3M	243	18	$30.2K

SUN Pharmaceutical Industries Limited ranks #3 among 238 Indian Gliclazide exporters. Average shipment value of $32.2K compared to the market average of $287.6K. The closest competitors by value are MICRO LABS LIMITED and IPCA LABORATORIES LIMITED.

Which Indian Ports Ship Gliclazide Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	439	11.5%
SAHAR AIR	375	9.8%
JNPT/ NHAVA SHEVA SEA	323	8.4%
SAHAR AIR CARGO ACC (INBOM4)	247	6.4%
DELHI AIR	229	6.0%
JNPT	203	5.3%
DELHI AIR CARGO ACC (INDEL4)	165	4.3%
CMA CGM LOGISTICS PARK ICD	103	2.7%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Gliclazide Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 484 individual customs records matching SUN Pharmaceutical Industries Limited exporting Gliclazide, covering 232 formulations to 11 countries via 47 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 643+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gliclazide

Gliclazide

SUN Pharmaceutical Industries Limited — Gliclazide Exporter Profile

SUN Pharmaceutical Industries Limited — Gliclazide Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Gliclazide?

Who Are the Top Buyers of Gliclazide from SUN Pharmaceutical Industries Limited?

What Is India's Total Gliclazide Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Gliclazide Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Gliclazide Exporters?

What Gliclazide Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Gliclazide to Key Markets

Brazil — ANVISA

Canada — HC

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Gliclazide Exporters?

Which Indian Ports Ship Gliclazide Exports?

Gliclazide — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Gliclazide Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gliclazide Export Data from SUN Pharmaceutical Industries Limited

Gliclazide Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source